Key statistics
On Wednesday, Vivoryon Therapeutics NV (VVY:AEX) closed at 1.45, 4.02% above its 52-week low of 1.39, set on Jun 24, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.43 |
---|---|
High | 1.47 |
Low | 1.43 |
Bid | -- |
Offer | -- |
Previous close | 1.46 |
Average volume | 44.78k |
---|---|
Shares outstanding | 26.23m |
Free float | 19.68m |
P/E (TTM) | -- |
Market cap | 38.35m EUR |
EPS (TTM) | -0.789 EUR |
Data delayed at least 15 minutes, as of Jul 09 2025 16:35 BST.
More ▼
- Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conferences
- Vivoryon Therapeutics N.V. Reports Outcome of 2025 Annual General Meeting
- Vivoryon Therapeutics N.V. Q1 2025 Financial Results and Operational Progress
- Vivoryon Therapeutics N.V. to Report Q1 2025 Financial Results and Operational Progress on June 17, 2025
- Vivoryon Therapeutics N.V. Presents Meta-analysis Data of VIVIAD and VIVA-MIND studies at ERA 2025
- Vivoryon Therapeutics N.V. Expands Intellectual Property Portfolio with New U.S. Composition of Matter Patent Granted for Varoglutamstat
- Vivoryon Therapeutics N.V. to Hold its 2025 Annual General Meeting on June 24, 2025
- Vivoryon Therapeutics N.V. Reports Full Year 2024 Financial Results and Provides Business Update
- Vivoryon Therapeutics N.V. Signs Financing Agreement for up to EUR 15 Million
- Vivoryon Therapeutics N.V. to Report Full Year 2024 Financial Results and Operational Progress on April 29, 2025
More ▼